![]() |
市場調查報告書
商品編碼
2141392
蛋清蛋白水解物市場機會、成長要素、產業趨勢分析及2026-2035年預測Egg Protein Hydrolysates Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
全球雞蛋蛋白水解物市場預計到 2025 年將價值 2.42 億美元,年複合成長率為 6.4%,到 2035 年將達到 4.449 億美元。
| 市場範圍 | |
|---|---|
| 開始年份 | 2025 |
| 預測期 | 2026-2035 |
| 初始市場規模 | 2.42億美元 |
| 預計金額 | 4.449億美元 |
| 複合年成長率 | 6.4% |
預計市場規模將從2025年的15,800千噸增加到2035年的25,700千噸。隨著食品和營養產業從傳統的雞蛋加工轉向高附加價值的功能性成分,雞蛋蛋白水解物的商業性重要性日益凸顯。其市場潛力不僅取決於蛋白質含量,還取決於用於將蛋白質分解成更短胜肽鏈的控制水解過程。這種加工技術可以改善特定配方中的消化率、溶解度和功能性。消費者對高蛋白營養、功能性成分、運動營養和特殊膳食產品的興趣日益濃厚,推動了對雞蛋來源肽類成分的需求。製造商也致力於研發能夠實現胜肽特性和應用性能一致性的加工技術。成熟的雞蛋加工基礎設施,加上對高品質營養成分日益成長的需求,正在為食品、膳食補充劑和臨床營養領域創造新的機會。隨著原料開發商不斷最佳化水解過程並擴大商業配方,預計到 2035 年,蛋清蛋白水解物將在更廣泛的應用領域中得到應用。
預計到2025年,蛋清水解物市場規模將達到1.077億美元,並在2035年之前以6.3%的複合年成長率成長。蛋清蛋白為開發具有各種功能特性的胜肽基原料提供了多樣化的基礎。其營養成分和加工靈活性使其在特種配方中持續應用。對蛋清水解物的研究表明,其吸收迅速,使其在運動營養和臨床營養應用中保持重要地位。胜肽配方的持續開發以及對易消化蛋白質原料日益成長的需求預計將在整個預測期內推動該細分市場的成長。
預計2025年,營養保健品應用領域市場規模將達6,780萬美元,2035年將達到1.198億美元。蛋源胜肽組分被添加到營養保健品配方中,用於促進消化健康、增強免疫力、維護心血管健康、抗氧化和抗發炎。消費者對功能性營養和健康成分日益成長的興趣,為蛋蛋白水解物在營養保健品領域創造了更多機會。
預計到2025年,北美蛋清蛋白水解物市場規模將達到9,560萬美元。其中,美國市場規模預計為6,090萬美元,這得益於其成熟的分銷和配方管道,服務於運動營養、機能飲料、膳食補充劑和臨床營養等領域。此外,完善的蛋白加工供應鏈也保障了原料的穩定供應,而加拿大則補充了區域加工能力,並促進了以出口為導向的原料貿易。
The Global Egg Protein Hydrolysates Market was valued at USD 242 million in 2025 and is estimated to grow at a CAGR of 6.4% to reach USD 444.9 million by 2035.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $242 Million |
| Forecast Value | $444.9 Million |
| CAGR | 6.4% |
Market volume is projected to increase from 15,800 kilo tons in 2025 to 25,700 kilo tons by 2035. Egg protein hydrolysates are gaining commercial importance as the food and nutrition industries move beyond conventional egg processing toward higher-value functional ingredients. Their market potential depends not only on their protein content but also on the controlled hydrolysis process used to break proteins into shorter peptide chains. This processing approach can improve digestibility, solubility, and functionality for targeted formulations. Growing consumer interest in protein-rich nutrition, functional ingredients, sports nutrition, and specialized dietary products is supporting demand for egg-derived peptide ingredients. Manufacturers are also focusing on processing technologies that can deliver consistent peptide characteristics and application performance. The combination of established egg-processing infrastructure and increasing demand for premium nutritional ingredients is creating opportunities across food, supplement, and clinical nutrition applications. As ingredient developers continue to optimize hydrolysis processes and expand commercial formulations, egg protein hydrolysates are expected to gain broader use through 2035.
Egg white hydrolysates segment held USD 107.7 million in 2025 and is forecast to grow at a CAGR of 6.3% through 2035. Egg white proteins provide a diverse foundation for developing peptide-based ingredients with different functional characteristics. Their nutritional profile and processing versatility continue to support their use in specialized formulations. Research on egg white hydrolysates has highlighted their potential for rapid absorption, which maintains their relevance across sports nutrition and clinical nutrition applications. Continued development of peptide formulations and increasing demand for easily digestible protein ingredients are expected to support segment growth during the forecast period.
Nutraceutical applications segment recorded USD 67.8 million in 2025 and is expected to reach USD 119.8 million by 2035. Egg-derived peptide fractions are incorporated into nutraceutical formulations designed around digestive health, immune support, cardiovascular wellness, antioxidant properties, and anti-inflammatory benefits. Increasing consumer interest in functional nutrition and health-focused ingredients is creating additional opportunities for egg protein hydrolysates within the nutraceutical sector.
North America Egg Protein Hydrolysates Market captured USD 95.6 million in 2025. The United States generated USD 60.9 million in 2025 and benefits from well-established distribution and formulation channels serving sports nutrition, functional beverages, dietary supplements, and clinical nutrition. Integrated egg-processing supply chains also support reliable access to feedstock, while Canada adds regional processing capabilities and contributes to export-focused ingredient trade.
Major companies operating in the global Egg Protein Hydrolysates market include Taiyo Kagaku Co. Ltd., Merck KGaA, Kewpie Corporation, IGRECA, and Rembrandt Foods. Companies in the global Egg Protein Hydrolysates market are strengthening their market foothold through product development, processing technology improvements, capacity expansion, strategic partnerships, and broader distribution networks. Manufacturers are investing in hydrolysis technologies that can improve peptide consistency, solubility, digestibility, and functionality across different formulations. Expanding product portfolios allows companies to address demand from nutraceutical, sports nutrition, clinical nutrition, and functional food applications. Strategic collaborations with food manufacturers, supplement brands, ingredient distributors, and research organizations are helping businesses accelerate formulation development and increase market access. Companies are also optimizing egg-processing and peptide-production operations to improve yields, quality control, and cost efficiency. Geographic expansion is supporting access to new customers and emerging nutrition markets. In addition, businesses are emphasizing technical support, customized ingredient solutions, regulatory compliance, and reliable supply capabilities to build long-term B2B relationships and strengthen their competitive positions.